Curis 10K 2013 Annual report | CRIS Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. junior Avg

New words: abbreviated, absorption, Academy, Acetylon, addressed, adult, advertising, AEs, alpha, ALT, antagonist, apportioned, asin, AST, AstraZeneca, BAY, Bayer, begun, belinostat, beta, bilirubin, birinapant, Bloomberg, breakthrough, buparlisib, burdensome, calendar, Canada, capecitabine, capped, carcinogenicity, Celleron, CHMP, circumstance, clarification, clarifying, clear, clock, complicating, compulsory, confirmatory, consumer, convey, copanlisib, Cowen, cytarabine, database, delta, detention, died, disagree, dispensed, DOJ, dossier, draft, duly, easily, eleven, entinostat, entrenching, EnVivo, enzyme, excretion, expedited, explain, explanation, exploratory, explore, explored, fallopian, fast, FDASIA, FDCA, follicular, frequency, front, ganetespib, gap, Gilead, givinostat, GlaxoSmithKline, goal, hand, HIPAA, hyperglycemia, hypersensitivity, idelalisib, IIB, illustrated, image, IMM, imprisonment, improperly, Incyte, indolent, ingredient, intermediate, intermittent, irreversible, isoform, IstodaxTM, Italfarmaco, Jaye, jointly, Kaposi, Kogyo, lag, leadership, leaflet, lengthy, linked, lymphoid, MALT, mammalian, marker, master, meant, media, MedImmune, MEI, metabolite, middle, mimetic, Mirati, MMA, mocetinostat, monotherapy, morbidity, mortality, MPH, mTOR, myelodysplastic, negligence, neutropenia, nondeductible, notification, Oncothyreon, optimal, ordinary, orphan, orqui, outpatient, panobinostat, PDMA, penalty, peripheral, pervasive, Pharma, physical, plc, poverty, PR, pracinostat, predicated, predominantly, preempted, preliminarily, proximity, purity, QTc, question, radiographic, rapamycin, rare, rarity, rash, reaction, reapprove, referenced, referencing, Relief, remit, remitted, remitting, reproductive, resminostat, restoration, resubmission, revocation, ricolinostat, Sanofi, shortfall, Smac, Spectrum, STEVIE, stringent, subpopulation, subtype, successor, surrogate, suspected, Syndax, Takeda, Taxpayer, teaching, TG, thought, thrombocytopenia, timeframe, today, track, tube, unamortized, unavailable, Unconfirmed, unsatisfactory, untreated, USPTO, Verastem, verify, version, viewpoint, Viner, Virginia, Wilex, writing, Zenyaku, ZolinzaTM

Removed: accompany, alter, arbitration, arisen, attain, attempting, attributed, billion, building, Cambridge, chain, chemotherapeutic, circumvented, cisplatin, conclusion, conform, congressional, Conservation, constitute, creating, CTA, curtail, Customer, decided, declaring, discharge, discharged, discouraging, discretionary, disseminate, environmental, exposure, facilitate, Gist, govern, HPV, Ib, instituting, investigator, judicially, killing, Leader, lieu, liquidation, Mark, Maryland, mid, Moulton, MPDIMA, mutual, NIH, Noel, nonrefundable, Nuclear, NV, Occupational, optimum, ordinarily, overhaul, participatory, peptide, petition, pharmacology, precedential, proportional, proven, radioactive, ratably, Recovery, reevaluate, refuse, release, reletting, reliable, renamed, rental, reversed, secrecy, settle, simultaneously, sublicensing, substantiation, supplement, tender, thereto, toxic, true, unapproved, unresolved, warrantholder, waste, withhold, worked

Curis (CRIS) 10-K2013 FY Annual report

Content analysis